1 Min Read
May 9 (Reuters) - Lupin Ltd
* Lupin ltd clarifies on news item "USFDA issues 8 observations for Aurangabad plant"
* Says co's Aurangabad facility underwent an inspection by US FDA subsequent to which US FDA issued form 483 citing 8 observations
* Says co in process of addressing these observations Source text: (bit.ly/2pqN2vW) Further company coverage: